AlrabiNTawilMD

PubMed

• Engineered FSHD mutations results in D4Z4 heterochromatin disruption and feedforward DUX4 network activation.
  Xiangduo Kong, Nam Viet Nguyen, Yumeng Li, Jasmine Shaaban Sakr, Kate Williams, Sheila Sharifi, Jonathan Chau, Altay Bayrakci, Seiya Mizuno, Satoru Takahashi, Tohru Ki...> ;Iscience. 2024 Apr 19
• Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression.
  Chao-Jen Wong, Seth D Friedman, Lauren Snider, Sean R Bennett, Takako I Jones, Peter L Jones, Dennis W W Shaw, Silvia S Blemker, Lara Riem, Olivia DuCharme, Richard J ...> ;Human Molecular Genetics. 2024 Apr 8
• A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).
  Varma, A., Eichinger, K., Heininger, S., Dilek, N., Martens, W., McDermott, M., Heatwole, C., Todinca, M., Tawil, R., Statland, J., Kissel, J.> ;Muscle & Nerve. 2024 Mar 1
• A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay Proteomics.
  Amy E Campbell, Jamshid Arjomand, Oliver D King, Rabi Tawil, Sujatha Jagannathan> ;Journal of Neuromuscular Diseases. 2023 Jan 1
• 2 citations
  Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophy.
  Richard J L F Lemmers, Russell Butterfield, Patrick J van der Vliet, Jan L de Bleecker, Ludo van der Pol, Diane M Dunn, Corrie E Erasmus, Marc D'Hooghe, Kristof Verhoe...> ;Brain. 2024 Feb 1
• 1 citations
  Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystro...
  Leung, D. G., Leo H Wang, Doris G Leung, Kathryn R Wagner, Sarah J Lowry, Michael P McDermott, Katy Eichinger, Kiley Higgs, Michaela Walker, Leann Lewis, William B Mar...> ;Neuromuscular Disorders. 2023 Sep 1
• Finding the Determinants of Disease Severity in Facioscapulohumeral Muscular Dystrophy.
  Rabi Tawil> ;Neurology. 2023 Jul 18
• 8 citations
  Facioscapulohumeral muscular dystrophy: the road to targeted therapies.
  Mara S Tihaya, Karlien Mul, Judit Balog, Jessica C de Greef, Stephen J Tapscott, Rabi Tawil, Jeffrey M Statland, Silvère M van der Maarel> ;Nature Reviews. Neurology. 2023 Feb 1
• 2 citations
  Milestones of progression in myotonic dystrophy type 1 and type 2.
  Johanna I Hamel, Michael P McDermott, James E Hilbert, William B Martens, Elizabeth Luebbe, Rabi Tawil, Richard T Moxley 3rd, Charles A Thornton> ;Muscle & Nerve. 2022 Oct 1
• 8 citations
  Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional Analysis.
  Michelle L Mellion, Per Widholm, Markus Karlsson, André Ahlgren, Rabi Tawil, Kathryn R Wagner, Jeffrey M Statland, Leo Wang, Perry B Shieh, Baziel G M van Engelen, Joo...> ;Neurology. 2022 Aug 30
• 2 citations
  Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatab...
  Per Widholm, André Ahlgren, Markus Karlsson, Thobias Romu, Rabi Tawil, Kathryn R Wagner, Jeffrey M Statland, Leo H Wang, Perry B Shieh, Baziel G M van Engelen, Diego C...> ;Muscle & Nerve. 2022 Aug 1
• 8 citations
  Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy.
  Jeffrey M Statland, Craig Campbell, Urvi Desai, Chafic Karam, Jordi Díaz-Manera, Jeffrey T Guptill, Lawrence Korngut, Angela Genge, Rabi N Tawil, Lauren Elman, Nanette...> ;Muscle & Nerve. 2022 Jul 1
• Reply: Wheelchair use in genetically confirmed FSHD1 from a large cohort study in Chinese population.
  Natalie K Katz, John Hogan, Ryan Delbango, Colin Cernik, Rabi Tawil, Jeffrey M Statland> ;Brain. 2022 Jun 30
• 8 citations
  Elevated plasma complement components in facioscapulohumeral dystrophy.
  Chao-Jen Wong, Leo Wang, V Michael Holers, Ashley Frazer-Abel, Silvère M van der Maarel, Rabi Tawil, Jeffrey M Statland, Stephen J Tapscott> ;Human Molecular Genetics. 2022 Jun 4
• 39 citations
  Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
  Michela Guglieri, Kate Bushby, Michael P McDermott, Kimberly A Hart, Rabi Tawil, William B Martens, Barbara E Herr, Elaine McColl, Chris Speed, Jennifer Wilkinson, Jan...> ;JAMA. 2022 Apr 19
• 5 citations
  Cytosolic adaptation to mitochondria-induced proteostatic stress causes progressive muscle wasting.
  Xiaowen Wang, Frank A Middleton, Rabi Tawil, Xin Jie Chen> ;Iscience. 2022 Jan 21
• 3 citations
  Understanding the Perseverance of the Muscular Dystrophy Community One-Year into the COVID-19 Pandemic.
  Leann Lewis, Katy Eichinger, Nuran Dilek, Kiley Higgs, Michaela Walker, David Palmer, John M Cooley, Nicholas Johnson, Rabi Tawil, Jeffrey Statland> ;Journal of Neuromuscular Diseases. 2022 Jan 1
• 3 citations
  Clinical and Genetic Characteristics in Young, Glucocorticoid-Naive Boys With Duchenne Muscular Dystrophy
  Marianela Schiava, Rachel Amos, Henriette VanRuiten, Michael P. McDermott, W. Martens, Stephanie Gregory, Anna Mayhew, Elaine McColl, Rabi Tawil, Tracey Willis, Kate B...> ;Neurology. 2021 Dec 2
• 1 citations
  A Roadmap to Patient Engagement: Facioscapulohumeral Muscular Dystrophy and the ReSolve Clinical Trial.
  Samantha LoRusso, Katy Eichinger, Kiley Higgs, Leann Lewis, Michaela Walker, James Albert, Michele Langer, Rabi Tawil, Jeffrey Statland, Kim S. Kimminau> ;Neurology. Clinical Practice. 2021 Oct 1
• 7 citations
  High resolution breakpoint junction mapping of proximally extended D4Z4 deletions in FSHD1 reveals evidence for a founder effect.
  Richard J.L.F. Lemmers, Patrick J. van der Vliet, David San Leon Granado, Nienke van der Stoep, Henk P. J. Buermans, Robin van Schendel, Joost Schimmel, Marianne de Vi...> ;Human Molecular Genetics. 2021 Sep 24
• 6 citations
  Predictors of functional outcomes in patients with facioscapulohumeral muscular dystrophy.
  Natalie K. Katz, John Hogan, Ryan Delbango, Colin Cernik, Rabi Tawil, Jeffrey Statland> ;Brain. 2021 Sep 20
• 6 citations
  A patient-focused survey to assess the effects of the COVID-19 pandemic and social guidelines on people with muscular dystrophy.
  Katy Eichinger, Leann Lewis, Nuran Dilek, Kiley Higgs, Michaela Walker, David L. Palmer, John M Cooley, Nicholas E. Johnson, Rabi Tawil, Jeffrey Statland> ;Muscle & Nerve. 2021 Jun 8
• A Pediatric Case of Granulomatous Myositis and Response to Treatment.
  Rabheh Abdul-Aziz, Henry J Sioufi, Chrisana Pokorny, Rabi Tawil> ;Cureus. 2021 Apr 15
• 9 citations
  The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS).
  Karlien Mul, Tatiana Hamadeh, Corinne G.C. Horlings, Rabi Tawil, Jeffrey Statland, Sabrina Sacconi, Alastair Corbett, Nicol C. Voermans, Catharina G. Faber, Baziel G.M...> ;European Journal of Neurology. 2021 Apr 10
• 16 citations
  Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy.
  Leo H. Wang, Dennis W. W. Shaw, Anna V. Faino, Christopher B. Budech, Leann Lewis, Jeffrey Statland, Katy Eichinger, Stephen J. Tapscott, Rabi Tawil, Seth D. Friedman> ;BMC Musculoskeletal Disorders. 2021 Mar 10
• Join now to see all

Journal Articles

• Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year  
  Kaufmann P, McDermott MP, Darras BT, Finkel R, Kang P, Oskoui M, Constantinescu A, Sproule DM, Foley AR, Yang M, Tawil R, Chung W, Martens B, Montes J, O'Hagen J, Duna..., Arch Neurol, 6/1/2011
• Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence  
  van der Maarel SM, Tawil R, Tapscott SJ, Trends Mol Med, 5/1/2011
• The authorship lottery: an impediment to research collaboration?  
  Kaufmann P, Annis C, Griggs RC; Muscle Study Group Executive Committee, Ann Neurol, 12/1/2010
• Clinical features of facioscapulohumeral muscular dystrophy 2  
  de Greef JC, Lemmers RJ, Camano P, Day JW, Sacconi S, Dunand M, van Engelen BG, Kiuru-Enari S, Padberg GW, Rosa AL, Desnuelle C, Spuler S, Tarnopolsky M, Venance SL, F..., Neurology, 10/26/2010
• Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene  
  Snider L, Geng LN, Lemmers RJ, Kyba M, Ware CB, Nelson AM, Tawil R, Filippova GN, van der Maarel SM, Tapscott SJ, Miller DG, PLoS Genet, 10/1/2010
• Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females  
  Stratigopoulos G, Lanzano P, Deng L, Guo J, Kaufmann P, Darras B, Finkel R, Tawil R, McDermott MP, Martens W, Devivo DC, Chung WK, Arch Neurol, 10/1/2010
• What determines quality of life in inclusion body myositis?  
  Sadjadi R, Rose MR; Muscle Study Group, J Neurol Neurosurg Psychiatry, 10/1/2010
• A unifying genetic model for facioscapulohumeral muscular dystrophy  
  Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camano P, Dauwerse JG, Snider L, Straasheijm KR, van Ommen GJ, Padberg GW, Miller DG, Tapscott SJ, Tawil R, Frants..., Science, 9/24/2010
• Grip force, EDL contractile properties, and voluntary wheel running after postdevelopmental myostatin depletion in mice  
  Personius KE, Jayaram A, Krull D, Brown R, Xu T, Han B, Burgess K, Storey C, Shah B, Tawil R, Welle S, J Appl Physiol, 9/1/2010
• Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei  
  Masny PS, Chan OY, de Greef JC, Bengtsson U, Ehrlich M, Tawil R, Lock LF, Hewitt JE, Stocksdale J, Martin JH, van der Maarel SM, Winokur ST, Eur J Hum Genet, 4/1/2010
• Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy  
  Montes J, McDermott MP, Martens WB, Dunaway S, Glanzman AM, Riley S, Quigley J, Montgomery MJ, Sproule D, Tawil R, Chung WK, Darras BT, De Vivo DC, Kaufmann P, Finkel ..., Neurology, 3/9/2010
• Resuscitated sudden cardiac death in Andersen-Tawil syndrome  
  Airey KJ, Etheridge SP, Tawil R, Tristani-Firouzi M, Heart Rhythm, 12/1/2009
• DNaseI hypersensitivity at gene-poor, FSH dystrophy-linked 4q352  
  Xu X, Tsumagari K, Sowden J, Tawil R, Boyle AP, Song L, Furey TS, Crawford GE, Ehrlich M, Nucleic Acids Res, 12/1/2009
• Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level  
  Klooster R, Straasheijm K, Shah B, Sowden J, Frants R, Thornton C, Tawil R, van der Maarel S, Eur J Hum Genet, 12/1/2009
• Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD  
  de Greef JC, Lemmers RJ, van Engelen BG, Sacconi S, Venance SL, Frants RR, Tawil R, van der Maarel SM, Hum Mutat, 10/1/2009
• Relation between extent of myostatin depletion and muscle growth in mature mice  
  Welle S, Burgess K, Thornton CA, Tawil R, Am J Physiol Endocrinol Metab, 10/1/2009
• Skeletal muscle gene expression aftermyostatin knockout in mature mice  
  Welle S, Cardillo A, Zanche M, Tawil R, Physiol Genomics, 8/7/2009
• RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy  
  Snider L, Asawachaicharn A, Tyler AE, Geng LN, Petek LM, Maves L, Miller DG, Lemmers RJ, Winokur ST, Tawil R, van der Maarel SM, Filippova GN, Tapscott SJ, Hum Mol Genet, 7/1/2009
• Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis  
  Wolfe GI, Barohn RJ, Sanders DB, McDermott MP; Muscle Study Group, Muscle Nerve, 11/1/2008
• A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis  
  Muscle Study Group, Neurology, 8/1/2008
• A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy  
  Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, J..., Ann Neurol, 5/1/2008
• Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers  
  Tsumagari K, Qi L, Jackson K, Shao C, Lacey M, Sowden J, Tawil R, Vedanarayanan V, Ehrlich M, Nucleic Acids Res, 4/1/2008
• Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity  
  Jackson CE, Barohn RJ, Gronseth G, Pandya S, Herbelin L; Muscle Study Group, Muscle Nerve, 4/1/2008
• Sex-related differences in gene expression in human skeletal muscle  
  Welle S, Tawil R, Thornton CA, PLoS One, 1/2/2008
• Facioscapulohumeral dystrophy  
  Pandya S, King WM, Tawil R, Phys Ther, 1/1/2008
• Join now to see all

Books/Book Chapters

• Cardiac Electrophysiology: From Cell to Bedside 
  Chapter: VTs in Andersen-Tawil Syndrome. 
  Tristani-Firouzi M, Tawil REditors: D.P. Zipes, J. Jalife.Elsevier SaundersEdition 6th,2014
• Neuromuscular Disorders in Clinical Practice 
  Chapter: Facioscapulohumeral muscular dystrophy. 
  Page 1251 - 1258Tawil REditors: Katirji B., Kaminski H.J. and Ruff R.L..Springer, New YorkEdition 2nd,2014
• Encyclopedia of Neurological Sciences 
  Chapter: Emery-Dreifuss, Facioscapulohumeral, Scapuloperoneal and Bethlem Myopathy. 
  Page 207 - 2010Statland J,Tawil REditors: Aminoff M.J. and Daroff RB.Academic Press, OxfordEdition 2nd,2014
• Epstein's Inborn Errors of Development 
  Chapter: KCJN2 and the Andersen-Tawil Syndrome. 
  Renner DR, Tawil R, Tristani-Firouzi M, Ptacek LJEditors: Robert P. Erickson and Anthony Wynshaw-Boris.Oxford University PressEdition 3rd,2012
• Encyclopedia of Life Sciences 
  Chapter: Facioscapulohumeral Muscular Dystrophy. 
  Tawil R, Van der Maarel SJohn Wiley & Sons, Ltd, Chichester2011
• Neuromuscular Disorders. Neurology in Practice Series 
  Chapter: Neuromuscular diseases: Approach to clinical diagnosis. 
  Page 1 - 5Venance S, Tawil REditors: R.N. Tawil and S. Venance.Blackwell publishing2011
• Neuromuscular Disorders. Neurology in Practice Series 
  Chapter: Fascioscapulohumeral muscular dystrophy. 
  Page 74 - 79Farmakidis C, Tawil REditors: R.N. Tawil and S. Venance.Blackwell publishing2011
• Current Neurology and Neuroscience Reports 
  Chapter: Facioscapulohumeral Muscular Dystrophy. 
  Tawil R2004
• The 5-Minute Neurology Consult 
  Chapter: Muscular Dystrophy, Facioscapulohumeral. 
  Page 286 - 287Cleland J, Tawil REditors: Lynn DJ, Newton HB, Rae-Grant AD.Lippincott Williams & Wilkins, Philadelphia, PA2004
• The Molecular and Genetic Basis of Neurologic and Psychiatric Disease 
  Chapter: Facioscapulohumeral Dystrophy. 
  Page 519 - 525Tawil REditors: Rosenburg RN, Prusiner SB, DiMauro S, Barchi RL, Nestler EJ.Butterworth Heinemann, Philadelphia, PAEdition 3rd,2003
• Inborn Errors of Development: The Molecular Basis of Clinical Disorders of Morphogenesis 
  Chapter: KCNJ2 (KIR2.1) and the Andersen Syndrome. 
  Renner DR, Tawil R, Tristani-Firouzi M, Ptacek LEditors: Epstein CJ, Erickson RP, Wynshaw-Boris A.Oxford University Press2003
• Current Therapy in Neurologic Disease 
  Chapter: Periodic Paralysis. 
  Page 422 - 424Tawil REditors: Johnson RT, Griggin JW, McArthur JC.Mosby, St. Louis2002
• Neuromuscular Disorders in Clinical Practice 
  Chapter: Facioscapulohumeral muscular dystrophy (FSHD). 
  Page 1072 - 1077Tawil REditors: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE.Butterworth Heinemann, Woburn, MA2002
• Channelopathies of the Nervous System 
  Chapter: The periodic paralyses: hyperkalaemic and hypokalemic paralysis. 
  Page 158 - 166Tawil REditors: Rose MR and Griggs RC.Butterworth-Heinemann, Oxford, Woburn2001
• Disorders of Voluntary Muscle 
  Chapter: Facioscapulohumeral muscular dystrophy. 
  Page 464 - 470Tawil R, Griggs RCEditors: Karpati G, Hilton-Jones D, Griggs RC.Cambridge University Press, Cambridge2001
• Neurogenetics 
  Chapter: Channelopathies. 
  Page 45 - 60Tawil R, Griggs RC, Rose MEditors: Pulst SM.EA Davis Company2000
• Seminars in Neurology 
  Chapter: Outlook for therapy in the muscular dystrophies. 
  Page 81 - 86Tawil REditors: Kissel J, Mendell JR.Theim, New York1999
• Pediatric Neurology 
  Chapter: Channelopathies: myotonic disorders and periodic paralysis. 
  Page 1299 - 1310Moxley III RT, Tawil R, Thornton CAEditors: Swaiman KF and Ashwal S.Mosby, St LouisEdition 3rd,1999
• The Molecular and Genetic Basis of Neurological Disease 
  Chapter: Facioscapulohumeral muscular dystrophy. 
  Page 931 - 938Tawil R, Griggs RCEditors: Rosenberg RN.Butterworth-Heinemann Publishers1997
• Handbook of Muscle Diseases 
  Chapter: Hypokalemic periodic paralysis. 
  Page 329 - 337Tawil R, Griggs RCEditors: Lane RJM.Marcel Dekker, Basel1996
• Recent Advances in Clinical Neurophysiology 
  Chapter: Implications of the molecular defects for classification and treatment of periodic paralysis. 
  Page 160 - 169Griggs RC, Tawil R, Brown RH, et alEditors: Kimura J and Shibasaki H.Elsevier Science B.V.1996
• Current Neurology 
  Chapter: Myotonic Disorders. 
  Page 1 - 28Moxley RT, Griggs RC, Tawil REditors: Appel SH.Mosby Year Book, Chicago1995
• Join now to see all

Abstracts/Posters

• Clinical and Molecular Biomarkers in FSHD.
  Tawil R, New Directions in Biology and Disease of Skeletal Muscle Conference, Chicago, IL, 6/29/2014
• Trial Readiness in FSHD.
  Tawil R, TREAT-NMD Alliance Conference, Newcastle, UK, 10/30/2013
• FSHD Therapeutics: Opportunities and Challenges.
  Tawil R, Muscle Study Group Annual Meeting, Oxford, UK, 9/16/2013
• Defining Workshop Aims.
  Tawil R, Clinical Trial Readiness Workshop in FSHD, Leiden, The Netherlands, 4/8/2013
• Advances in FSHD Research & Genetic Testing.
  Tawil R, FSH Society International Patient & Research Network Meeting, Las Vegas, NV, 7/31/2010
• New Findings in FSHD.
  Tawil R, MRC/MDC UK Neuromuscular Translational Research Conference, Oxford, UK, 3/26/2010
• FSHD: Clinical Trial Readiness.
  Tawil R, 171st International ENMC Workshop, Naarden, The Netherlands, 1/15/2010
• FSHD Clinical Manifestations & Molecular Genetics: An Update.
  Tawil R, 9th Congress of Mediterranean Society of Myology, Cyprus, 3/19/2009
• Molecular Pathophysiology of FSHD.
  Tawil R, Wellstone Seminar, John Hopkins Hospital, Baltimore, MD, 2/2/2009
• Mechanisms of Disease in Facioscapulohumeral Muscular Dystrophy (FSHD).
  Tawil R, New Directions in Biology and Disease of Skeletal Muscle, New Orleans, LA, 4/27/2008
• FSHD: Natural History Studies.
  Tawil R, St. Radboud University Medical Center, Nijmegen, The Netherlands, 11/4/2007
• FSHD Research in the USA.
  Tawil R, Dutch FSH Symposium, Vlaardingen, The Netherlands, 11/2/2007
• Periodic Paralysis and Non-Dystrophic Myotonias.
  Tawil R, Neurogenetics for the Practitioner Course, New York University School of Medicine, New York, NY, 11/9/2006
• FSH Dystrophy: Chipping Away at an Intractable Mystery.
  Tawil R, Frontiers in Neuroscience, UCSF, San Francisco, CA, 1/26/2005
• Update on Facioscapulohumeral Muscular Dystrophy.
  Tawil R, FSH Society Patient Day Conference, Rockville, MD, 10/13/2002
• Role of DEXA scan in neuromuscular disorders.
  Tawil R, MSG Annual Meeting, Beaver Hollow, NY, 9/20/2002
• Therapeutic Trials in Periodic Paralysis: Andersen's Syndrome.
  Tawil R, ENMC International Workshop, Naarden, The Netherlands, 3/24/2001
• Therapeutic Trials in Periodic Paralysis: Measuring Attack Frequency & Severity.
  Tawil R, ENMC International Workshop, Naarden, The Netherlands, 11/25/2000
• FSHD: Diagnostic Criteria Revisited.
  Tawil R, Third International Conference on the Cause and Treatment of FSH Dystrophy, Campus of the National Institutes of Health, Bethesda, MD, 5/8/2000
• Outlook for therapy for the muscular dystrophies.
  Tawil R, American Academy of Neuro­logy Course: Update on Myopathies, AAN 51th Annual Meeting, Toronto, Canada, 4/24/1999
• Current and potential treatments of the muscular dystrophies.
  Tawil R, AAN Annual Meeting, 4/19/1999
• Clinical Diagnostic Criteria and the FSHD Patient.
  Tawil R, International Conference on the Cause and Treatment of FSH Dystrophy, AAN Satellite Symposium, Boston, 4/12/1997
• Evaluation and treatment of muscle cramps.
  Tawil R, Neurology For The Primary Care Physician, SUNY, Syracuse, NY, 5/17/1996
• Open label trial of Predni­sone in Facioscapulohumeral dystrophy (FSHD).
  Tawil R, McDermott M, Griggs RC and FSH-DY Group, ANA Annual Meeting, Seattle, WA, 5/11/1995
• Twins discordant for FSH muscular dystrophy. Unusual diagnostic and management problems in neuromuscular disease I.
  Tawil R, AAN Meeting, New York, NY, 4/26/1993
• Join now to see all

Lectures

• Clinical Trials: Current and Impending; 2016 Patient Connect 
  https://www.youtube.com/watch?v=Ao7t5yb0RsI - 12/1/2016
• FSHD: Clinical Manifestations and Care Guidelines; FSHDGlobalResearch, Australia 
  https://www.youtube.com/watch?v=PReXnyvm9nQ - 10/18/2015
• FSHD Evidence-based Care Guidelines; FSH Society podcast 
  https://www.youtube.com/watch?v=ekE3PSw65to - 10/1/2015
• Neurology Grand Rounds: "FSHD: Translating Genetic Discoveries into Treatment" 
  SUNY Downstate Medical Center, New York, NY - 6/14/2013
• Neurology Grand Rounds: "Translating FSHD Genetics into Treatments." 
  UT San Antonio, TX - 6/7/2013
• Neurology Grand Rounds: "FSHD: Translating Genetic Discoveries into Treatments." 
  Ohio State University, Columbus, OH - 12/11/2012
• Grand Rounds: "FSH Dystrophy: Teaching an Old Gene New Tricks." 
  Department of Neurology, University of Rochester Medical Center - 10/12/2012
• "FSHD: State of the Art" (Invited Speaker) 
  Orlando, FL - 10/3/2012
• "FSHD: Clinical and Genetic Update." 
  University of Rochester Medical Center - 5/12/2012
• "Things to do before you die: Get a disease named after you." 
  1/30/2012
• "Amyotrophic Lateral Sclerosis." 
  11/1/2011
• Junk DNA and Disease: How a Dormant Gene Causes Muscular Dystrophy. 
  3/18/2011
• "Keynote Speaker" 
  BBRI NIH NICHD Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center for FSHD, Wa - 5/25/2010
• "Pathophysiology of FSHD: An Update." 
  Albany Medical Center, Albany, NY - 5/21/2009
• "Andersen Tawil Syndrome." 
  University of Rochester Medical Center - 1/9/2009
• Pediatric Neurology Grand Rounds: "Periodic Paralysis and Non-Dystrophic Myotonias." 
  Schneider Children's Hospital,North shore-Long Island Jewish Health System - 1/1/2009
• "FSHD: Clinical and Research Update" 
  University of Rochester Medical Center, Rochester, NY - 10/24/2008
• "MSG Coordination Center." 
  Beaver Hollow, NY - 9/16/2008
• "Fields Center for FSHD and Neuromuscular Research" 
  Bethesda, MD - 6/23/2008
• Neuroscience Grand Rounds: "Neuromuscular Channelopathies" 
  Upstate Medical University, Syracuse, NY - 5/16/2007
• Neurology Grand Rounds"The periodic paralysis: Evolving clinical and molecular concepts." 
  Cleveland Clinic Foundations, Cleveland, OH - 10/25/2005
• "Recent Advances in Facioscapulohumeral Muscular Dystrophy." 
  London, Ontario, Canada - 2/5/2005
• "Facioscapulohumeral Muscular Dystrophy" (Guest Speaker) 
  Toronto, Canada - 10/23/2004
• "Andersen's Syndrome." 
  University of Rochester Medical Center - 8/20/2004
• "Facioscapulohumeral Muscular Dystrophy (FSHD): Untangling a Molecular Enigma" 
  University of Rochester Medical Center - 3/1/2004
• Join now to see all

Other

• Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions. 
  Tawil R, Statland J, AANEM Physician Podcasts
  https://www.aanem.org/Education/CME-Opportunities/PhyPodcasts-(1).aspx?page=4&fileid=965
  11/9/2012
• CD ROM: "Facioscapulohumeral mususcular dystrophy.; Gilman S, Goldstein GW, Waxman SG, eds; Neurobase; San Diego: Arbor Publishing" 
  Tawil R, Medlink
  1/1/2011
• Facioscapulohumeral muscular dystrophy. 
  Tawil R, AANEM Physician Podcasts
  http://www.aanem.org/Education/CME-Opportunities/PhyPodcasts-(1).aspx?fileid=345
  9/4/2006
• "Andersen-Tawil Syndrome.; Pagon RA, Bird TD, Dolan CR, Stephens K, editors" 
  Tawil R, Venance SL, GeneReviews (Internet)
  University of Washington, Seattle, WA - 11/22/2004
• CD ROM: "Periodic paralyses and associated disorders, Gilman S, Goldstein GW, Waxman SG, eds; Neurobase; San Diego: Arbor Publishing" 
  Tawil R, Mankodi A, Medlink, 2000-2003 (updated yearly)
  1/1/2004
• "Facioscapulohumeral Muscular Dystrophy" 
  Figlewicz D, Tawil R, GeneReviews
  http://www.geneclinics.org/profiles/fsh/details.html
  University of Washington, Seattle - 3/8/1999
• Join now to see all